CIK: 1207114 - Address: C/O Canaan Partners, 2765 Sand Hill Road, Menlo Park, CA 94025
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111138272010-239
P%wins100100100100100083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/4/21 17:50
8/2/21
RLYBRallybio CorpHealthDrugPharmaceutical PreparationsShannon Timothy MCTDP.d1,00013.0007732,410I
6/19/20 17:00
6/17/20
ARVNArvinas, Inc.DEHealthDrugPharmaceutical PreparationsShannon Timothy MCTDP6130.260204,569D
6/4/20 21:00
6/2/20
ARVNArvinas, Inc.DEHealthDrugPharmaceutical PreparationsShannon Timothy MCTDP.d9732.300304,567D
3/23/20 19:01
3/20/20
ARVNArvinas, Inc.DEHealthDrugPharmaceutical PreparationsShannon Timothy MCTDP10040.000304,551D
5/28/19 16:56
5/28/19
IDYAIdeaya Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsShannon Timothy MCTDP.d4,00010.000400182,661I
5/13/19 19:33
5/13/19
NXTCNextcure, Inc.DEHealthDrugPharmaceutical PreparationsShannon Timothy MCTDP.d75015.0005022,254I
4/1/19 17:11
3/28/19
ARVNArvinas, Inc.DEHealthDrugPharmaceutical PreparationsShannon Timothy MCTDP5114.690405,048D
10/3/18 17:25
10/1/18
ARVNArvinas Inc.DEHealthDrugPharmaceutical PreparationsShannon Timothy MCTDP.d6416.000405,045M
9/13/10 09:37
9/10/10
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticShannon Timothy MMADP173.41350D-68-37-33-32-32-21-191138272010-23

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact